Jul 18 |
Biora Therapeutics Announces Supplemental Data from Phase 1 Clinical Trial of BT-600 as Presented at KOL Event
|
Jul 8 |
Biora Therapeutics to Host Virtual KOL Event on NaviCap™ Targeted Oral Delivery Platform and Results from Phase 1 Clinical Trial of BT-600 on July 17, 2024
|
Jul 8 |
BIOR: BT-600 Topline
|
Jul 1 |
Biora Therapeutics Announces Positive Clinical Trial Results for BT-600
|
Jun 11 |
Biora Therapeutics Announces Presentation on the BioJet™ Systemic Oral Delivery Platform at the Next Gen Peptide Formulation & Delivery Summit 2024
|
May 20 |
Biora Therapeutics Presents Clinical Data on Device Function of the NaviCap™ Platform at Digestive Disease Week 2024
|
May 16 |
BIOR: BT-600 Data in June
|
May 16 |
Biora Therapeutics Inc (BIOR) Q1 2024 Earnings Call Transcript Highlights: Navigating Through ...
|
May 15 |
Biora Therapeutics, Inc. (BIOR) Q1 2024 Earnings Call Transcript
|
May 15 |
Biora Therapeutics GAAP EPS of -$0.14 beats by $0.31, revenue of $0.54M
|